NCT06791174View on ClinicalTrials.gov

Tumor Microenvironmental Collagen Signature to Predict Thyroid Cancer Superior Mediastinal Lymph Node Metastasis

CompletedOBSERVATIONAL
Enrollment

181

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Thyroid Cancer
Trial Locations (1)

Unknown

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors
collaborator

Nanfang Hospital, Southern Medical University

OTHER

collaborator

Sir Run Run Shaw Hospital

OTHER

lead

The First Affiliated Hospital of Zhengzhou University

OTHER

NCT06791174 - Tumor Microenvironmental Collagen Signature to Predict Thyroid Cancer Superior Mediastinal Lymph Node Metastasis | Biotech Hunter | Biotech Hunter